Legal Representation
Attorney
Jenevieve J. Maerker, Esq.
USPTO Deadlines
Next Deadline
972 days remaining
Section 8 Declaration Due (Supplemental Register) (Based on registration date 20220816)
Due Date
August 16, 2028
Grace Period Ends
February 16, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
26 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 16, 2022 | NRCS | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Aug 16, 2022 | R.SR | A | REGISTERED-SUPPLEMENTAL REGISTER | Loading... |
| Jul 11, 2022 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Jul 10, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jul 7, 2022 | CNTA | O | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | Loading... |
| Sep 28, 2021 | AAUA | E | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED | Loading... |
| Sep 27, 2021 | IUAA | P | USE AMENDMENT ACCEPTED | Loading... |
| Sep 25, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 24, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 24, 2021 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Sep 25, 2021 | AUPC | I | AMENDMENT TO USE PROCESSING COMPLETE | Loading... |
| Sep 25, 2021 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Sep 24, 2021 | EAAU | I | TEAS AMENDMENT OF USE RECEIVED | Loading... |
| Mar 24, 2021 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Mar 24, 2021 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Mar 24, 2021 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Feb 26, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 26, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 26, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 31, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 31, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 31, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 24, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 10, 2020 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jun 9, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 26, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
House mark for pharmaceuticals
First Use Anywhere:
Sep 23, 2021
First Use in Commerce:
Sep 23, 2021
Additional Information
Design Mark
The mark consists of the stylized words "HOMOLOGY MEDICINES, INC." with a curved design intersecting the letter "H" in "HOMOLOGY". The word "HOMOLOGY" is presented in gray, with the words "MEDICINES, INC." in light blue underneath the right half of the word "HOMOLOGY." The crossbar of the letter "H" in "HOMOLOGY" is replaced with a curved design in light blue that begins to the left of the H, curves up through the "H", and ends above the letter "O" adjacent to the "H". The blue color of this design fades from saturated to pale from left to right.
Color Claim
The color(s) gray, and light blue is/are claimed as a feature of the mark.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"MEDICINES, INC."